CNL announces joint venture in production of cancer-fighting isotope | Kingston/Frontenac This Week
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
Stay updated with breaking news from Alpha Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale...
GARCHING, Germany, MUNICH Germany and CHALK RIVER, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL),
New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope
On track to report topline data from the Pivotal Phase 3 SIERRA trial for Iomab-B in Q4 2022 Overall survival data from the Actimab-A CLAG-M combination trial...